T. Pasquine

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis

R. D. Gross, S. J. Lichtenstein, S. Robertson, 2007, Advances in therapy.

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.

R. D. Gross, M. Abelson, S. Robertson, 2004, Clinical therapeutics.

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis*

M. Abelson, S. Robertson, P. Gomes, 2005, Current medical research and opinion.